Showing results (51-60 of 2,407) with videos related to

Sort By:
Pageof 241
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
Lung cancerH H Hansen, M Rørth
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
Lung cancerH H Hansen, M Rørth
Nordisk Veterinaermedicin|October 1, 1982
Cadmium and zinc in kidneys from Danish cattleA Andersen, H H Hansen
Cancer Treatment Reviews|July 9, 1999
Surgery in limited stage small cell lung cancerU Lassen, H H Hansen
Gegenbaurs Morphologisches Jahrbuch|January 1, 1977
[Comparative and functional morphology of musculus canalis ani in tetrapod mammals and primates]H H Hansen, H Heine
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Lung cancerH H Hansen, M Rørth
Lancet (London, England)|July 11, 1987
Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapyJ Pedersen-Bjergaard, L Specht, S O Larsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow upU Lassen, P E Kristjansen, K Osterlind, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1986
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials groupU Bruntsch, P Dodion, W W Ten Bokkel Huinink, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1976
Separation of labelled iodide, iodoprotein, iodotyrosines, and iodothronines in serum from patients treated with iodine-131, using an improved chromatographic methodK J Olsen, H H Hansen
Pageof 241